News & Blog

Tag Archives: Oligodendroglioma

Potential Brain Tumor Treatments Entering the Pivotal Phase of Evaluation – June 2018

A large, randomized, controlled Phase III clinical trial is traditionally the last, pivotal step in the evaluation of a potential new medicine before it is approved for use by all patients with the indicated disease. A year ago, the NBTS staff conducted and published a review of all the Phase III clinical trials for glioblastoma […]

NBTS Scientific Summit 2017: Making a “New Map” for Brain Tumor Research & Treatment Development

Twelve questions to answer that will drive the brain tumor research field forward “I think that this year is even more accelerated in progress than last year. Lots of new things, lots of new possibilities…we really are all pushing together and trying to get to the top of the mountain.” With those words, Dr. Web […]

Brain Tumor Research Highlights: May 2017

See April’s Brain Tumor Research Highlights, here. Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship research projects – […]

Share